← back to search

Weiqiang Chen

Northwell Health ·
Area of research
Public Health, Environmental and Occupational Health · Immunology
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, interferon and immune responses, and Immune Response and Inflammation.
h-index
27
citations
3,246
works
88
NIH funding
primary concept
email

Recent publications

Sustained chronic inflammation and altered childhood vaccine responses in children exposed to Zika virus
EBioMedicine 2024cited by 10position: middledoi
Neuromotor repertoires in infants exposed to maternal COVID-19 during pregnancy: a cohort study
BMJ Open 2023cited by 31position: middledoi
Corrigendum to “Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis” [Biomater. 161 (2018) 164–178]
Biomaterials 2022cited by 3position: lastdoi
The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2
Cell Reports Medicine 2021cited by 64position: middledoi
Zika virus vertical transmission in children with confirmed antenatal exposure
Nature Communications 2020cited by 47position: middledoi
Association Between Neonatal Neuroimaging and Clinical Outcomes in Zika-Exposed Infants From Rio de Janeiro, Brazil
JAMA Network Open 2019cited by 75position: middledoi
Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen
The Lancet Infectious Diseases 2017cited by 498position: middledoi
Asian Zika virus strains target CD14+ blood monocytes and induce M2-skewed immunosuppression during pregnancy
Nature Microbiology 2017cited by 161position: middledoi
Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation
Nature Microbiology 2017cited by 95position: firstdoi
Hsa-mir-499 rs3746444 T/C Polymorphism is Associated with Increased Risk of Coronary Artery Disease in a Chinese Population.
PubMed 2017cited by 16position: firstdoi
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
Cell stem cell 2016cited by 560position: middledoi
Dengue virus therapeutic intervention strategies based on viral, vector and host factors involved in disease pathogenesis
Pharmacology & Therapeutics 2012cited by 53position: middledoi

Grants

I-Corps: Bioengineered Chimeric Antigen Receptor (CAR) Chips for Screening CAR T-Cell Immunotherapy
NSF2221959$50,0002022–2023PIRePORTER
Bioengineering Leukemic Bone Marrow Niche for Dissecting the Heterogeneous Leukemia Chemo-resistance Mechanisms
NSF2103219$314,0002021–2024PIRePORTER
Collaborative Research: Plasmofluidic Nanoantenna-Superlens Biosensor for Single-Cell Functional Immunophenotyping
NSF1701322$279,2242017–2021PIRePORTER

Frequent collaborators

Suan‐Sin Foo · Agency for Science, Technology and Research5 papers (2016–2024)Jae U. Jung · Cleveland Clinic4 papers (2016–2024) · 3 papers (2017–2024)Adam Taylor · Griffith University3 papers (2012–2017)Suresh Mahalingam · Griffith University3 papers (2012–2017)Karin Nielsen‐Saines · Mercy Hospital for Women3 papers (2017–2024)Lara J. Herrero · Griffith University3 papers (2012–2017)Stefan Wolf · Humboldt-Universität zu Berlin2 papers (2012–2017)Lisa F. P. Ng · Agency for Science, Technology and Research2 papers (2017–2017)Jianning Ge · University of Southern California2 papers (2016–2017)Ali Zaid · University of Jordan2 papers (2017–2017)Mary Catherine Cambou · University of California, Los Angeles2 papers (2023–2024)Weiyi Qian · New York University1 papers (2022–2022)Raymond Lam · University of Nottingham1 papers (2022–2022) · 1 papers (2017–2017)James W. Bowman · Institute for Protein Innovation1 papers (2017–2017)Jean‐Pierre Gagner · New York University1 papers (2022–2022)Kuo‐Ching Sheng · Griffith University1 papers (2012–2012) · 1 papers (2024–2024)Tamiris Azamor · Cleveland Clinic Lerner College of Medicine1 papers (2024–2024)